Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200064308Phase 4Not yet recruiting
Phase 4, randomised trial of oxycodone in postoperative delirium (POD) and postoperative pain (2 arms), sponsored by The Affiliated Hospital of Jiaxing University. Primary endpoint: Incidence of postoperative delirium. Planned start Oct 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200064308.